| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 541 |
端乙炔基聚醚酰亚胺改性硅芳炔树脂（PEI-PSA） |
5 |
WYQ |
2024-11-22 |
| 542 |
DOTA 偶联肽,NOTA-E(cRGDfK)2,NOTA标记多肽氨基酸试剂 |
2 |
kx |
2024-11-22 |
| 543 |
Lutetium (177Lu) oxodotreotide；437608-50-9 |
5 |
wyh |
2024-11-22 |
| 544 |
CAS：2125661-62-1 Butyne-DOTA |
4 |
zyl |
2024-11-22 |
| 545 |
端乙炔基聚醚酰亚胺（PEI）（Polyetherimide，简称PEI） |
4 |
WYQ |
2024-11-22 |
| 546 |
碳/聚硅乙炔基防热复合材料（C/PMR） |
3 |
WYQ |
2024-11-22 |
| 547 |
聚（间二乙炔基苯-甲基氢硅烷）树脂（PSA） |
3 |
WYQ |
2024-11-22 |
| 548 |
P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔（PAnPE） |
6 |
WYQ |
2024-11-22 |
| 549 |
DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 |
3 |
zcy |
2024-11-22 |
| 550 |
DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 |
3 |
zyl |
2024-11-22 |
| 551 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester |
3 |
wyh |
2024-11-22 |
| 552 |
DOTA功能化的聚赖氨酸 |
6 |
zcy |
2024-11-22 |
| 553 |
聚乳酸-羟基乙酸共聚物-大环配体 |
3 |
wyh |
2024-11-22 |
| 554 |
DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide |
3 |
zcy |
2024-11-22 |
| 555 |
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
3 |
wyh |
2024-11-22 |
| 556 |
BKT140CXCR4 antagonist-DOTA |
3 |
zyl |
2024-11-22 |
| 557 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
4 |
zyl |
2024-11-22 |
| 558 |
DOTA di(tBu)ester；913542-71-9 |
2 |
wyh |
2024-11-22 |
| 559 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸]，三氟乙酸盐；1175002-77-3 |
3 |
wyh |
2024-11-22 |
| 560 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
4 |
wyh |
2024-11-22 |
| 561 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
3 |
zcy |
2024-11-22 |
| 562 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
4 |
wyh |
2024-11-22 |
| 563 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
4 |
zcy |
2024-11-22 |
| 564 |
DOTA-HYNIC-IPSMA |
3 |
wyh |
2024-11-22 |
| 565 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
3 |
zcy |
2024-11-22 |
| 566 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
3 |
zyl |
2024-11-22 |
| 567 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
3 |
wyh |
2024-11-22 |
| 568 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
3 |
zcy |
2024-11-22 |
| 569 |
DOTA-octreotide,大环配体奥曲肽 |
3 |
zyl |
2024-11-22 |
| 570 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
3 |
wyh |
2024-11-22 |
| 571 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
4 |
zcy |
2024-11-22 |
| 572 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
4 |
zcy |
2024-11-22 |
| 573 |
DOTA-NT8-13(靶向NTR1) |
3 |
zcy |
2024-11-22 |
| 574 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
2 |
wyh |
2024-11-22 |
| 575 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
2 |
wyh |
2024-11-22 |
| 576 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
3 |
wyh |
2024-11-22 |
| 577 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
4 |
wyh |
2024-11-22 |
| 578 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
3 |
zcy |
2024-11-22 |
| 579 |
钆布醇杂质20 ；229312-34-9 |
3 |
wyh |
2024-11-22 |
| 580 |
DOTA-[Nle]-cCCK 科研定制 |
4 |
zcy |
2024-11-22 |
| 581 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
2 |
wyh |
2024-11-22 |
| 582 |
FITC-PEG2-TATE ；1027160-33-3 |
3 |
wyh |
2024-11-22 |
| 583 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
3 |
zcy |
2024-11-22 |
| 584 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
4 |
zcy |
2024-11-22 |
| 585 |
RGD-DOTA的结构特点 |
3 |
wyh |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询